Riskpilot← Back to searchSign inGet full accessBIOTRANS AS
ASActiveOrg 997791444Lørenveien 59A, 0585 OsloFreight transport by road · NACE 4941Est. 2012114 employees
Revenue 2021
NOK 25,5M
+12% vs 2020
EBITDA margin
17.5%
+31% vs 2020
Equity ratio
62.5%
Financial strength
Net profit 2021
NOK 3M
+31% vs 2020
| Revenue | NOK 25,5M | +12% |
| EBITDA | NOK 4,5M | +31% |
| Net profit | NOK 3M | +31% |
| Total assets | NOK 10,2M | +13% |
| Equity | NOK 6,4M | +82% |
| Employees | 114 | — |
Legal name
BIOTRANS AS
Org number
997791444
Legal form
Aksjeselskap
NACE code
4941 · Freight transport by road
Founded
7. januar 2012
Share capital
NOK 3 000 000
Employees
114 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Godstransport på vei og alt hva derved står i forbindelse, samt kjøp og salg av musikkinstrument og lignende produkter naturlig tilhørende dette. Selskapet driver også med investeringer i aksjer og andeler i andre selskaper.
Address
Lørenveien 59A, 0585 Oslo
Phone
+4792868361
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 13 169 | 17 337 | 18 634 | 22 723 | 25 492 |
| Staff expenses | −4 794 | −6 220 | −6 876 | −7 367 | −7 734 |
| EBITDA | 2 248 | 2 763 | 2 835 | 3 388 | 4 453 |
| Depreciation & amort. | −330 | −417 | −384 | −419 | −351 |
| EBIT | 1 918 | 2 346 | 2 451 | 2 969 | 4 102 |
| Net financials | −22 | −21 | −356 | −11 | −180 |
| Profit before tax | 1 896 | 2 325 | 2 095 | 2 958 | 3 922 |
| Tax | 466 | 540 | 538 | 652 | 900 |
| Net profit | 1 430 | 1 785 | 1 557 | 2 306 | 3 023 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 4 934 | 5 515 | 6 178 | 9 031 | 10 194 |
| Equity | 1 054 | 1 339 | 1 696 | 3 502 | 6 376 |
| Long-term debt | 559 | 370 | 160 | 256 | 173 |
| Short-term debt | 3 321 | 3 806 | 4 322 | 5 273 | 3 645 |
| Total debt | 3 880 | 4 176 | 4 482 | 5 529 | 3 818 |
EBITDA margin
17.5%
This company
15.8%
Market median
+11% vs market
20172021
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
20172021
Return on equity
47.4%
This company
18.4%
Market median
+158% vs market
20172021
Net profit margin
11.9%
This company
8.1%
Market median
+47% vs market
20172021
Asset turnover
2.50×
This company
1.12×
Market median
+123% vs market
20172021
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NK Deputy Member | Deputy Member | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOTRANS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Knapper Lunde | Deputy Member | 0 companies |
| Trond Ove Lunde | Chairman | 0 companies |